Project #62: LGR4-ECD: A potential therapeutic for type 1 diabetes-related beta cell stress
This grant funds research into how LGR4-ECD could reduce beta cell stress and improve survival in type 1 diabetes, with the goal of developing new therapeutic strategies.
Funder: Diabetes Research Connection
Due Dates: Rolling (open submission)
Funding Amounts: Up to $75,000 per project; typically for 1 year of research.
Summary: Supports early-career scientists investigating innovative approaches to improve pancreatic beta cell health and function in type 1 diabetes.
Key Information: Funding is awarded via a donor-driven, peer-reviewed process; open to novel, T1D-focused projects.
Description
This funding opportunity supports research into LGR4-ECD as a potential therapeutic for reducing beta cell stress and improving outcomes in type 1 diabetes (T1D). The project aims to uncover how LGR4-ECD, a protein, can block harmful pathways that increase beta cell death and dysfunction under stress conditions associated with T1D. By evaluating its effects in both cultured cells and animal models, the research seeks to establish new strategies for preserving beta cell viability and function, with the ultimate goal of identifying innovative treatments for T1D.
